BMRN vs ELSE · P/E 40, rev $2.85B vs P/E 41, $16.3M cap
Biomarin Pharmaceutical Inc (BMRN) versus Electro-Sensors Inc (ELSE) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
Electro-Sensors Inc (ELSE) is a scientific & technical instruments company listed on US.
Latest reported BMRN revenue for 2024-12-31 was $2.85B. Net income was $426.9M. Revenue was up 18.0% from 2023-12-31 to 2024-12-31. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
ELSE does not have a complete income-statement cache yet.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. ELSE currently screens at market cap $16.3M and trailing P/E 41.5.
Not investment advice. Open the BMRN and ELSE stock pages for the full models.
Not investment advice.